Computational platform, chemical libraries, and analytics combining massively parallel in-silico simulation with empirical protein-structure analysis to design biotherapeutics that modulate protein–protein interactions. Generates therapeutic antibody candidates enriched for on-target, on-epitope binding and optimized modes of action for pharma and biotech drug-discovery teams.